NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
21.5%
Industry median - 13.4%
5Y Historical average - 91.5%
(46.9%)
Industry median - 1.1%
5Y Historical average - (13.5%)
(36.3%)
Industry median - (20.2%)
5Y Historical average - (12.5%)
N/A
Industry median - (1.2%)
5Y Historical average - 7.4%
ALNY Growth Rating
Crunching data... Almost there!
ALNY Growth Metrics
Crunching data... Almost there!
Competing with ALNY Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Alnylam Pharmaceuticals, Inc. (ALNY) revenue growth?
The Alnylam Pharmaceuticals, Inc. (ALNY) revenue growth is 21.5%, which is lower than the industry median of 13.4% and the 5-year historical average of 91.5%.
What is the Alnylam Pharmaceuticals, Inc. (ALNY) operating income growth?
The Alnylam Pharmaceuticals, Inc. (ALNY) operating income growth is (46.9%), compared to the industry median of 1.1% and the 5-year historical average of (13.5%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) EPS (Earnings Per Share) growth?
The Alnylam Pharmaceuticals, Inc. (ALNY) EPS growth is (36.3%), compared to the industry median of (20.2%) and the 5-year historical average of (12.5%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF) growth?
The Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow growth is N/A, compared to the industry median of (1.2%) and the 5-year historical average of 7.4%.